Dolby Laboratories, Inc.
DLB
Revenue
288.82M
▼-75.71M▼-20.77%
3 Months ChangeAssets
2.97B
▼-71.09M▼-2.33%
3 Months ChangeLiabilities
526.20M
▼-80.84M▼-13.32%
3 Months ChangeFree Cash Flow
2.31M
▼-46.87M▼-95.30%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-19
Form 8-K
ID: 0001193125-24-202859
2024-08-07
Form 10-Q
ID: 0001628280-24-035707
2024-08-07
Form 8-K
ID: 0001193125-24-195903
2024-06-06
Form 8-K
ID: 0001193125-24-155603
2024-05-02
Form 10-Q
ID: 0001628280-24-020061
2024-05-02
Form 8-K
ID: 0001193125-24-129380
2024-02-09
Form 8-K
ID: 0001193125-24-030031
2024-02-02
Form 10-Q
ID: 0001628280-24-002964
2024-02-01
Form 8-K
ID: 0001193125-24-021860
2023-11-16
Form 8-K
ID: 0001193125-23-278816